Impact Factor
3.74
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
5.18
419 total citations
h5-index
40
h5 depth signal
Cited share
75.6%
62 of 82
Total citations
419
Citation footprint
Metric signal
4.40
External metric anchor
Self-citation
4.8%
20 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
320
Italy
142
United Kingdom
119
Germany
60
China
59
Citing Fields of Research
Immunology
124
Diabetes
97
Cellular Membrane Transporters & Receptors
89
Neurosciences
77
Neurodegenerative Disorders
66
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
2,963
Articles tracked across the journal lifetime
Indexed publication set
82
62 cited publications
Last 12 months
68
5.7 publications/month
Open access share
11.8%
8 OA publications in the last year
Leading citing country
United States
320 citing publications
Leading citing field
Immunology
124 citing publications
Latest tracked publication
13 October 2026
10 recent records available
Coverage & Indexing History
v1n1, Feb. 2001-
v1n1, Feb. 2001-
Active Coverage
Research Focus & Classification
Indexed Subjects
Drug Delivery Systems
Inflammatory Bowel Diseases & Infections
Anesthetic & Pain Medicine
Immunology
Neurodegenerative Disorders
Neurosciences
Broad Categories
Pharmacology
Cellular Membrane Transporters & Receptors
Ophthalmology
DNA Damage
Hematology
Cancer, Autophagy & Apoptosis
Digestive Disorders
MeSH Descriptors
Biopharmaceutics
Drug Therapy
Pharmaceutical Preparations
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1016/j.coph.2026.102681
Open DOI
NOD1 and Neurodegenerative Diseases: Exploring the Interplay Between Innate Immune Signaling and Cognitive Decline
02
DOI 10.1016/j.coph.2026.102682
Open DOI
Nanomedicines and drug delivery systems for modulating immune training in cancer and infectious diseases
03
DOI 10.1016/j.coph.2026.102679
Open DOI
Advancing Analgesic Development for Peripheral Neuropathic Pain: Multi-Targeting Sodium Channels
04
DOI 10.1016/j.coph.2026.102680
Open DOI
Advanced Glycation, Endothelial Dysfunction, and the LDL Paradox: Is It Truly the ‘Bad’ Lipid?
05
DOI 10.1016/j.coph.2026.102678
Open DOI
Polycystic ovary syndrome: An insight into pathophysiology, current management, and emerging therapeutic approaches
06
07
DOI 10.1016/j.coph.2026.102677
Open DOI
Therapeutic targeting of trained immunity in cancer
08
09
DOI 10.1016/j.coph.2026.102675
Open DOI
Pharmacological control of inflammation via innate immune memory manipulation
10
DOI 10.1016/s1471-4892(26)00067-6
Open DOI
Editorial Board
Bibliographical & Catalog Notes
Also issued online.
v. 1, no. 1 (Jan. 2001)20011126 Notice not published Printed on acid-free paper